Jasper Therapeutics JSPR
NASDAQ JSPR
$0.51 +0.01 (+2.40%)
As of: Oct 21, 2026 · 9:40 AM EDT

Jasper Therapeutics (JSPR) Restructuring Costs (2024 - 2025)

Updated

Jasper Therapeutics' Restructuring Costs was $15.77 million in Q2 2025, up 154.1% from $6.21 million a year earlier and up 61.6% from the prior quarter.

Analysis

Jasper Therapeutics (JSPR) Restructuring Costs (2024 - 2025) Analysis & Trends

On a trailing twelve-month basis, Jasper Therapeutics' Restructuring Costs was $37.85 million through Jun 30, 2025; for FY2024, it was $34.27 million, down 6.8% from FY2023.

  • In earlier years, Restructuring Costs was $36.78 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,140.41 Bn 1,108.99 Bn 19.71 Bn
2 Johnson & Johnson 618.57 Bn 537.10 Bn 17.26 Bn
3 AbbVie 509.95 Bn 483.06 Bn 12.70 Bn
4 Merck 366.63 Bn 321.01 Bn 12.21 Bn
5 Novartis Ag 298.47 Bn 262.46 Bn 11.24 Bn
6 Astrazeneca 263.21 Bn 236.89 Bn 12.86 Bn
7 Amgen 236.71 Bn 192.11 Bn 7.24 Bn
8 Gilead Sciences 193.05 Bn 167.25 Bn 6.22 Bn
9 Pfizer 171.45 Bn 118.10 Bn 10.94 Bn
10 Jasper Therapeutics 14.69 Mn -111.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 15.77 Mn
Mar 31, 2025 9.76 Mn
Jun 30, 2024 6.21 Mn
Mar 31, 2024 6.11 Mn
API Access

Jasper Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=JSPR&period=max&api_key=YOUR_API_KEY